
Capping the cost of insulin: altruistic or strategic?
The price of insulin has become one of the most talked about issues across the pharma industry.
Newsletters and Deep Dive digital magazine
The price of insulin has become one of the most talked about issues across the pharma industry.
On 17th March, the PM Society held its 37th annual awards at the JW Marriott Grosvenor House.
AI technology isn’t designed to replace clinicians - its function is to help them.
How emerging technology could make healthcare more accessible for Spanish-speaking communities.
For both big pharma and small, partnership just makes sense.
Editor's Picks
Newsletters and Deep Dive
digital magazine